Biodexa Pharmaceuticals Plc November 27, 2023 - by Joey Ramson $BDRX is up over 100% and the leader of the Nasdaq after the company entered an agreement to acquire Adhera Therapeutics’s rights to tolimidone, a potential diabetes treatment Share this article:
